News
Company news 
ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing
Company news 
Singapore’s National Precision Medicine (NPM) programme engages Oxford Nanopore to advance understanding of the genetics of Singapore’s multi-ethnic p
Company news 
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
Company news 
Oxford Nanopore and Kaust collaborate to advance multi-omic discovery
Company news 
Oxford Nanopore Technologies and Dubai Health to collaborate on genetic screening
Company news 
Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
Company news 
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterise drug resistant-tuberculosis
Company news 
Oxford Nanopore, Action for ME, and University of Edinburgh launch groundbreaking study into the genetics of ME
Company news 
Blog: Ruminating on the rumen microbiome
Company news 
Blog: Resolving structural variants causing antithrombin deficiency
Company news 
Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants
Company news 
Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?
Company news 
London Calling 2025 Technology Update: Oxford Nanopore unveils path to a true multiomics future
Company news 
Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032
Company news APAC Rare Disease Consortium launched to advance genomic innovation and rare disease diagnosis